Systemic Inflammation Increases Risk for Chronic Kidney Disease
By Lori Solomon HealthDay Reporter
FRIDAY, March 22, 2024 -- Systemic inflammation is associated with an elevated risk for chronic kidney disease, according to a study published online Feb. 20 in Frontiers in Immunology.
Xiaoxin Liu, from Tongji Medical College at the Huazhong University of Science and Technology in Wuhan, China, and colleagues investigated the relationship between the systemic immune-inflammation index (SII) and chronic kidney disease. The analysis included 10,787 adults participating in the 2007 to 2018 National Health and Nutrition Examination Survey.
The researchers found that when adjusting for confounders, a higher SII increased the risk for incident chronic kidney disease (odds ratio, 1.36). The restricted cubic spline curve showed a positive, nonlinear correlation between SII per 1,000 and chronic kidney disease incidence. There was a stronger correlation observed for men (odds ratio, 2.628) versus women (odds ratio, 1.733).
"Our findings suggest that higher SII values are associated with the incidence of chronic kidney disease, and this influence is more noticeable in the male population," the authors write. "Numerous pathophysiologic alterations are responsible for the development of chronic kidney disease, and immunological dysfunction and elevated inflammation may be key players in this process."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
Women Face Worse Chronic Kidney Disease Management in Primary Care
MONDAY, May 20, 2024 -- Women receive worse primary care-based chronic kidney disease (CKD) management than men, according to a research letter published online May 16 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.